Archive - February 2025
Small Change: FDA’s Final Predetermined Change Control Plan (PCCP) Guidance Ditches ML and Adds Some Details, But Otherwise Sticks Closely to the Draft
Gilead Treatment for PBC Granted EC Conditional Marketing Authorization
Pharma Pulse 2/24/25: Enhancing Pharma Supply Chain Transparency and Trust, Growing Obesity Crisis is Driving Up Healthcare Costs & more
STAT+: J&J sues Samsung over a contract breach for a Stelara biosimilar
Powering Clinical Operations With Knowledge Graphs and LLMs With Merck KGaA, Darmstadt, Germany
How Technology is Impacting Launch Strategy Timelines
Boehringer Ingelheim Launches Trivalent Vaccine for H5 Avian Influenza
STAT+: Some NIH study sections will resume grant reviews, but final funding decisions are still in limbo